NEW YORK (GenomeWeb) – Luminex reported after the close of the market Monday that its fourth quarter revenues rose 8 percent year over year, in line with preliminary estimates.

For the three months ended Dec. 31, 2017, the firm reported revenues rose to $78.2 million from $72.3 million a year ago, beating the analysts' consensus estimate of $77.0 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.